US House passes resolution on "ethnic cleansing" of Rohingyas

Agencies
December 6, 2017

Washington, Dec 6: The US House of Representatives has condemned "ethnic cleansing" of Rohingya Muslims and called on Myanmar's leadership to end attacks on minorities in the northern Rakhine state, in the stiffest congressional criticism of the government in the Buddhist-majority country.

The House passed a resolution yesterday, urging immediate restoration of humanitarian access to the Rakhine state where unrest has forced over 600,000 Rohingya Muslims to flee to Bangladesh.

"This slaughter must end, and our resolution ought to send a strong message to Burmese leaders that their commitment to restoring democracy will be judged by their respect for the individual rights and freedoms of all people living within Burma's borders, no matter their faith or ethnicity," House Democratic Whip Steny H Hoyer said in a statement.

Introduced by Congressmen Joe Crowley and Eliot Engel, the resolution condemns the "horrific actions" of the military and security forces and calls for an immediate cessation of violence.

The resolution also urges the restoration of humanitarian access to the restive Rakhine state where unrest has forced hundreds of thousands of Rohingya Muslims to flee to Bangladesh.

"It also calls for Aung San Suu Kyi (Myanmar's de facto leader) to exercise moral leadership, something that's needed now more than ever," Engel said in his remarks on the House floor yesterday.

"We reject the Army's claims that what's taking place in Burma is a so-called counterterrorism measure that's nonsense. It's a textbook ethnic cleansing, that's what it is," Engel said.

"We should also encourage other governments to stay engaged and continue to address the pressing needs of these refugees' needs that will only grow as long as this situation remains unresolved," he said.

Clashes erupted after the August 25 deadly attacks by militants on security forces in the Rakhine State, sparking a major army crackdown on the community.

According to the UN estimates, more than 600,000 members of the minority Muslim group have fled across the border into Bangladesh since then, triggered a grave humanitarian crisis in the country.

"Bangladesh deserves our deep gratitude for opening its doors to the Rohingya at a time when our government slams the door shut," Engel said.

"The governments of Burma and Bangladesh have struck a deal to begin repatriating Rohingya next month, but it's not yet clear that anyone is interested in returning right now," he said.

Congresswoman Betty McCollum, who visited the refugee camps in Bangladesh last month, said that as Congressional fact-finding mission has noted their visits to refugee camps and conversations with survivors made it clear that the persecution of the Rohingya people in Burma's Rakhine State is a "severe humanitarian crisis that demands robust" American leadership.

"This resolution is an important first step in demonstrating that Congress will not tolerate human rights abuses against Rohingyas. As our delegation saw, there is a path forward. The Burmese government and military must fully implement the recommendations of former UN Secretary General Kofi Annan's advisory commission," McCollum said.

Meanwhile in Geneva, at a special session on Myanmar by United Nations Human Rights Council, the US called for all actors to play a constructive role in resolving the human rights situation and hold perpetrators of human rights violations accountable.

"The United States urges an immediate end to violence, restoration of the rule of law, countrywide access for the UN Fact-Finding Mission, immediate humanitarian and media access to affected areas, and guaranteed and verifiably safe, voluntary, and dignified return for those who want to return to their homes," State Department Spokesperson Heather Nauert said.

Respect for human rights of all peoples is a fundamental element of democracy and the US stands ready to support the elected civilian government in its efforts to achieve peace, stability, and prosperity for all of Burma, she said in a statement.

Congressman Steve Chabot said Rohingyas had long been at the fringe of Burmese society and it is no secret that the Burmese military regards them as outsiders who don't belong in Burma at all.

"That is why they used attacks in August, by a rogue group of Rohingya, as a pretext to terrorise the entire Rohingya population," he alleged.

"This campaign of terror and violence has worked over 600,000 Rohingya have fled Burma for Bangladesh. At least 250,000 of these are children. Further, credible human rights organisations and the media have documented numerous horrors and abuses.

"Together, these atrocities amount to what has been called a 'textbook example of ethnic cleansing'," Chabot alleged on the House floor.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
July 29,2020

If everything goes as Russia’s expectation, it will be world’s first country to approve a coronavirus vaccine for widespread in the second week of August despite safety and efficacy concerns, according to a report. The adenoviral vector-based vaccine developed by Russian military and government researchers is currently in phase 2 trials.

According to a report from CNN, Russian officials are hoping to get approval for the COVID-19 vaccine developed by the Moscow-based Gamaleya Institute on Agust 10 or even before that. The officials told the outlet that the vaccine will be approved for public use with frontline healthcare workers receiving it first.

“It’s a Sputnik moment,” said Kirill Dmitriev, head of Russia’s sovereign wealth fund, which is financing Russian vaccine research, referring to the successful 1957 launch of the world’s first satellite by the Soviet Union, according to CNN.

“Americans were surprised when they heard Sputnik’s beeping. It’s the same with this vaccine. Russia will have got there first,” he was quoted as saying.

However, Russia is yet to release the scientific data on its coronavirus vaccine trials, hence, questions remain about the safety and efficacy of the vaccine, said the report. The vaccine is in the second phase of testing with developers planning to launch the phase 3 trials sometime after August 3.

Earlier, Interfax reported, citing Health Minister Mikhail Murashko, that the vaccine will be widely used in parallel with phase 3 trials. He said the country plans to vaccinate medics who are at high-risk for COVID-19 next month before clinical trials are completed.

Murashko added that individuals at higher risk of getting infected with the coronavirus such as older people or those with health conditions will also be prioritised for the vaccine, although he did not estimate or reveal when that would happen. The minister added 800 people will be recruited for the phase 3 trials.

Meanwhile, health officials were more cautious considering the fact that human testing of the vaccine is incomplete, and the state registration is expected to begin after August 3, reported The Moscow Times.

On Monday, Moderna and Pfizer announced the commencement of the final phase 3 trials of their candidate vaccines against the SARS-CoV-2 virus, which has so far claimed at least 654,477 lives and infected 16,514,500 people worldwide. 

Researchers will recruit up to 30,000 volunteers in separate trials both backed by the US government. India's first indigenous coronavirus vaccine, COVAXIN, is undergoing phase 1 human clinical trials across the country. More than 150 COVID-19 vaccines are being developed all over the world with at least six candidates already in late-stage clinical trials.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 20,2020

Washington, Apr 20: The US wants to send a team of experts to China to investigate coronavirus, President Donald Trump has said, a day after he warned Beijing of "consequences" if it was knowingly responsible for the spread of COVID-19 which has killed more than 165,000 people globally, including over 41,000 in America.

Describing the coronavirus as a plague, Trump, during his White House news conference on Sunday, said that he is not happy with China where the pandemic emerged in December last year in the central Chinese city of Wuhan.

“We spoke to them (Chinese) a long time ago about going in. We want to go in. We want to see what's going on. And we weren't exactly invited, I can tell you that,” the President told reporters.

“I was very happy with the (trade) deal (with China), very happy with everything and then we found out about the plague and since we found out about that I'm not happy,” he said.

The US has launched an investigation into whether the deadly virus "escaped" from the Wuhan Institute of Virology.

He has repeatedly expressed disappointment over China's handling of the coronavirus disease, alleged non-transparency and initial non-cooperation from Beijing with Washington on dealing with the crisis.

“Based on an investigation, we are going to find out,” Trump told reporters.

A day earlier, he warned China that it should face consequences if it was "knowingly responsible" for the spread of the novel coronavirus, upping the ante on Beijing over its handling of the COVID-19 pandemic.

“If they (China) were knowingly responsible… then there should be consequences. You're talking about, you know, potentially lives like nobody's seen since 1917,” Trump said on Saturday.

The opposition Democratic Party said that Trump has falsely claimed he acted early by restricting travel from China when it was little too late and he continued to downplay the virus throughout February.

The number of COVID-19 deaths in the US crossed 41,000 and the total infections were more than 764,000 so far.

New York, the epicentre of the deadly COVID-19 in the US, has 2,42,000 cases and over 17,600 fatalities so far. It has registered a 50-percent decline in new cases over an eight-day period.

The novel virus, which emerged in China in December last year, has killed over 160,000 and infected more than 2.3 million people worldwide.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 25,2020

Beijing, Mar 25: Around 5,000 people have signed up for the phase I clinical trial of recombinant novel coronavirus vaccine in Chinese city Wuhan where the virus first emerged late last year.

The recruitment for participants ended this week with nearly 5,000 volunteers signing up for the trial, state-run Beijing News reported on Wednesday.

A single-centre, open and dose-escalation phase I clinical trial for recombinant novel coronavirus vaccine (adenoviral vector) will be tested in healthy adults aged between 18 and 60 years, according to the ChiCTR (China Clinical Trial Register).

The trial, led by experts from the Academy of Military Medical Sciences, gained its approval on March 16 and the research is expected to last half a year.

Requiring at least 108 participants, the trial will be conducted in Wuhan, capital of Hubei province, the region worst-affected by the virus in the country, state-run China Daily reported.

Participants will experience 14-day quarantine restrictions after being vaccinated and their health condition will be recorded every day.

Chinese scientists are hastening the development of COVID-19 vaccines through five approaches --- inactivated vaccines, genetic engineering subunit vaccines, adenovirus vector vaccines, nucleic acid vaccines and vaccines using attenuated influenza virus as vectors.

So far, most teams are expected to complete preclinical research in April and some are moving forward faster, Wang Junzhi, an academician with the Chinese Academy of Engineering said.

Wang noted that research and development of COVID-19 vaccines in China is not slower than foreign counterparts and has been carried out in a scientific, standardised and orderly way.

China has stepped up the process to finalise vaccines to counter COVID-19 after Kaiser Permanente research facility in Seattle and Washington stole the march and began human trials.

China lifted tough restrictions on the Hubei province on Wednesday after a months-long lockdown as the country reported no new domestic cases.

But there were another 47 imported infections from overseas, the National Health Commission said. In total, 474 imported infections have been diagnosed in China -- mostly Chinese nationals returning home.

Comments

Y UDAYA CHANDAR
 - 
Monday, 13 Apr 2020

Dear Sir,

 

I am 77 but a very healthy person with remarkable immunity. I contracted Malaria fever in 1994 because of mosquito biting and I have not been sick anytime there after, not even for ordinary fever in the last 26 years.

 

I am sure you would like to conduct the trials on persons of varying criteria. I am sure you don't want to carry out the trials on perfectly healthy young individuals only. 

 

I am certain that  you want to try the vaccine on a 'common man' from 'general public.' I am ready for the trial and you can take me. I will be delighted. 

 

If you are not handling this matter kindly forward this mail to the correct agency.

 

I look forward to hearing from you.

 

Best regards.

 

If you are not moving forward, you are really moving backward.

Y Udaya Chandar

 

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.